Correlation Between Monopar Therapeutics and 437076BN1
Specify exactly 2 symbols:
By analyzing existing cross correlation between Monopar Therapeutics and HOME DEPOT INC, you can compare the effects of market volatilities on Monopar Therapeutics and 437076BN1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of 437076BN1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and 437076BN1.
Diversification Opportunities for Monopar Therapeutics and 437076BN1
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Monopar and 437076BN1 is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and HOME DEPOT INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HOME DEPOT INC and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with 437076BN1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HOME DEPOT INC has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and 437076BN1 go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and 437076BN1
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 67.57 times more return on investment than 437076BN1. However, Monopar Therapeutics is 67.57 times more volatile than HOME DEPOT INC. It trades about 0.39 of its potential returns per unit of risk. HOME DEPOT INC is currently generating about 0.11 per unit of risk. If you would invest 2,446 in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of 2,265 from holding Monopar Therapeutics or generate 92.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Monopar Therapeutics vs. HOME DEPOT INC
Performance |
| Timeline |
| Monopar Therapeutics |
| HOME DEPOT INC |
Monopar Therapeutics and 437076BN1 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and 437076BN1
The main advantage of trading using opposite Monopar Therapeutics and 437076BN1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, 437076BN1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 437076BN1 will offset losses from the drop in 437076BN1's long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| 437076BN1 vs. The Gap, | 437076BN1 vs. Grocery Outlet Holding | 437076BN1 vs. Titan Machinery | 437076BN1 vs. Torm PLC Class |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |